Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 598

1.

Performance and ease of use of a molecular point-of-care test for influenza A/B and RSV in patients presenting to primary care.

Verbakel JY, Matheeussen V, Loens K, Kuijstermans M, Goossens H, Ieven M, Butler CC.

Eur J Clin Microbiol Infect Dis. 2020 Mar 14. doi: 10.1007/s10096-020-03860-5. [Epub ahead of print]

PMID:
32172369
2.

Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid.

Palmieri M, D'Andrea MM, Pelegrin AC, Mirande C, Brkic S, Cirkovic I, Goossens H, Rossolini GM, van Belkum A.

Front Microbiol. 2020 Feb 21;11:294. doi: 10.3389/fmicb.2020.00294. eCollection 2020.

3.

A comparative study between real-time PCR and loop-mediated isothermal amplification to detect carbapenemase and/or ESBL genes in Enterobacteriaceae directly from bronchoalveolar lavage fluid samples.

Vergara A, Moreno-Morales J, Roca I, Pitart C, Kostyanev T, Rodriguez-Baño J, Goossens H, Marco F, Vila J.

J Antimicrob Chemother. 2020 Feb 19. pii: dkaa031. doi: 10.1093/jac/dkaa031. [Epub ahead of print]

PMID:
32073602
4.

How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018.

Wouters I, Desmet S, Van Heirstraeten L, Herzog SA, Beutels P, Verhaegen J, Goossens H, Van Damme P, Malhotra-Kumar S, Theeten H, NPcarriage Study Group.

Euro Surveill. 2020 Feb;25(5). doi: 10.2807/1560-7917.ES.2020.25.5.1900303.

5.

Antibiotic use and resistance in Belgium: the impact of two decades of multi-faceted campaigning.

Bruyndonckx R, Coenen S, Hens N, Vandael E, Catry B, Goossens H.

Acta Clin Belg. 2020 Feb 5:1-9. doi: 10.1080/17843286.2020.1721135. [Epub ahead of print]

PMID:
32024450
6.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, Bleicker T, Brünink S, Schneider J, Schmidt ML, Mulders DGJC, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MPG, Drosten C.

Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.

7.

Point prevalence survey of antimicrobial use and healthcare-associated infections in Belgian acute care hospitals: results of the Global-PPS and ECDC-PPS 2017.

Vandael E, Latour K, Goossens H, Magerman K, Drapier N, Catry B, Versporten A; Belgian Point Prevalence Survey Study Group.

Antimicrob Resist Infect Control. 2020 Jan 13;9:13. doi: 10.1186/s13756-019-0663-7. eCollection 2020.

8.

BacPipe: A Rapid, User-Friendly Whole-Genome Sequencing Pipeline for Clinical Diagnostic Bacteriology.

Xavier BB, Mysara M, Bolzan M, Ribeiro-Gonçalves B, Alako BTF, Harrison P, Lammens C, Kumar-Singh S, Goossens H, Carriço JA, Cochrane G, Malhotra-Kumar S.

iScience. 2020 Jan 24;23(1):100769. doi: 10.1016/j.isci.2019.100769. Epub 2019 Dec 12.

9.

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial.

Butler CC, van der Velden AW, Bongard E, Saville BR, Holmes J, Coenen S, Cook J, Francis NA, Lewis RJ, Godycki-Cwirko M, Llor C, Chlabicz S, Lionis C, Seifert B, Sundvall PD, Colliers A, Aabenhus R, Bjerrum L, Jonassen Harbin N, Lindbæk M, Glinz D, Bucher HC, Kovács B, Radzeviciene Jurgute R, Touboul Lundgren P, Little P, Murphy AW, De Sutter A, Openshaw P, de Jong MD, Connor JT, Matheeussen V, Ieven M, Goossens H, Verheij TJ.

Lancet. 2020 Jan 4;395(10217):42-52. doi: 10.1016/S0140-6736(19)32982-4. Epub 2019 Dec 12.

PMID:
31839279
10.

Detection of colistin resistance in the highly virulent Escherichia coli ST131 H30Rx clone in Greece.

Dafopoulou K, Xavier BB, Zarkotou O, Orfanidou M, Goossens H, Tsakris A, Malhotra-Kumar S, Pournaras S.

J Glob Antimicrob Resist. 2019 Nov 28;20:31-32. doi: 10.1016/j.jgar.2019.11.014. [Epub ahead of print] No abstract available.

11.

Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives.

Vandael E, Magerman K, Coenen S, Goossens H, Catry B.

Euro Surveill. 2019 Nov;24(46). doi: 10.2807/1560-7917.ES.2019.24.46.1900098.

12.

Global point prevalence survey of antimicrobial consumption in Brazilian hospitals.

Porto APM, Goossens H, Versporten A, Costa SF; Brazilian Global-PPS Working Group.

J Hosp Infect. 2020 Feb;104(2):165-171. doi: 10.1016/j.jhin.2019.10.016. Epub 2019 Nov 1.

PMID:
31678430
13.

Mechanical Ventilation Impairs IL-17 Cytokine Family Expression in Ventilator-Associated Pneumonia.

De Winter FHR, 's Jongers B, Bielen K, Mancuso D, Timbermont L, Lammens C, Van Averbeke V, Boddaert J, Ali O, Kluytmans J, Ruzin A, Malhotra-Kumar S, Jorens PG, Goossens H, Kumar-Singh S.

Int J Mol Sci. 2019 Oct 12;20(20). pii: E5072. doi: 10.3390/ijms20205072.

14.

THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.

Korinteli IG, Mchedlishvili I, Javakhadze M, Versporten A, Goossens H, Phagava H, Pagava K.

Georgian Med News. 2019 Jul-Aug;(292-293):72-75.

PMID:
31560667
15.

Murine iPSC-derived microglia and macrophage cell culture models recapitulate distinct phenotypical and functional properties of classical and alternative neuro-immune polarisation.

Quarta A, Le Blon D, D'aes T, Pieters Z, Hamzei Taj S, Miró-Mur F, Luyckx E, Van Breedam E, Daans J, Goossens H, Dewilde S, Hens N, Pasque V, Planas AM, Hoehn M, Berneman Z, Ponsaerts P.

Brain Behav Immun. 2019 Nov;82:406-421. doi: 10.1016/j.bbi.2019.09.009. Epub 2019 Sep 13.

16.

A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections.

Sigfrid L, Perfect C, Rojek A, Longuere KS, Lipworth S, Harriss E, Lee J, Salam A, Carson G, Goossens H, Horby P.

BMC Med. 2019 Sep 6;17(1):170. doi: 10.1186/s12916-019-1387-5.

17.

Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).

Loebinger MR, Polverino E, Blasi F, Elborn SJ, Chalmers JD, Tiddens HA, Goossens H, Tunney M, Zhou W, Angyalosi G, Hill AT, Haworth CS; iBEST-1 Trial Team.

Pulm Pharmacol Ther. 2019 Oct;58:101834. doi: 10.1016/j.pupt.2019.101834. Epub 2019 Aug 18.

PMID:
31433997
18.

Antibiotic utilisation in adult and children patients in Kosovo hospitals.

Krasniqi S, Versporten A, Jakupi A, Raka D, Daci A, Krasniqi V, Deva Z, Rashiti A, Brajshori N, Hajdari S, Bytyqi J, Neziri B, Goossens H, Raka L.

Eur J Hosp Pharm. 2019 May;26(3):146-151. doi: 10.1136/ejhpharm-2017-001363. Epub 2017 Oct 25.

PMID:
31428322
19.

Global Divergence From World Health Organization Treatment Guidelines for Neonatal and Pediatric Sepsis.

Jackson C, Hsia Y, Basmaci R, Bielicki J, Heath PT, Versporten A, Goossens H, Sharland M.

Pediatr Infect Dis J. 2019 Nov;38(11):1104-1106. doi: 10.1097/INF.0000000000002433.

PMID:
31425329
20.

Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.

Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, Molenberghs G, Hens N, Goossens H, Willekens B, Cras P, Ponsaerts P, Berneman ZN, Martínez-Cáceres EM, Cools N.

J Neuroinflammation. 2019 Aug 15;16(1):167. doi: 10.1186/s12974-019-1541-1.

21.

Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients.

Bruyndonckx R, Latour K, Atud GA, Dubovy P, Jaspers S, Hens N, Catry B, Goossens H, Coenen S.

J Antimicrob Chemother. 2019 Nov 1;74(11):3264-3267. doi: 10.1093/jac/dkz323.

PMID:
31377782
22.

Genomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae.

Garriss G, Nannapaneni P, Simões AS, Browall S, Subramanian K, Sá-Leão R, Goossens H, de Lencastre H, Henriques-Normark B.

mBio. 2019 Jun 25;10(3). pii: e01286-19. doi: 10.1128/mBio.01286-19.

23.

Asymptomatic bacteriuria in older adults: the most fragile women are prone to long-term colonization.

Biggel M, Heytens S, Latour K, Bruyndonckx R, Goossens H, Moons P.

BMC Geriatr. 2019 Jun 21;19(1):170. doi: 10.1186/s12877-019-1181-4.

24.

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries.

Hsia Y, Lee BR, Versporten A, Yang Y, Bielicki J, Jackson C, Newland J, Goossens H, Magrini N, Sharland M; GARPEC and Global-PPS networks.

Lancet Glob Health. 2019 Jul;7(7):e861-e871. doi: 10.1016/S2214-109X(19)30071-3.

25.

Variations in antibiotic use across India: multi-centre study through Global Point Prevalence survey.

Singh SK, Sengupta S, Antony R, Bhattacharya S, Mukhopadhyay C, Ramasubramanian V, Sharma A, Sahu S, Nirkhiwale S, Gupta S, Rohit A, Sharma S, Raghavan V, Barman P, Sood S, Mamtora D, Rengaswamy S, Arora A, Goossens H, Versporten A.

J Hosp Infect. 2019 Nov;103(3):280-283. doi: 10.1016/j.jhin.2019.05.014. Epub 2019 Jun 3.

26.

The Influence of Graft Length and Density on Dispersion, Crystallisation and Rheology of Poly(ε-caprolactone)/Silica Nanocomposites.

Eriksson M, Hamers J, Peijs T, Goossens H.

Molecules. 2019 Jun 3;24(11). pii: E2106. doi: 10.3390/molecules24112106.

27.

Quality of molecular detection of vancomycin resistance in enterococci: results of 6 consecutive years of Quality Control for Molecular Diagnostics (QCMD) external quality assessment.

Matheeussen V, Loens K, Scott C, Di Lorenzo C, McCulloch E, Donoso Mantke O, Goossens H, Wallace P, Ieven M.

Eur J Clin Microbiol Infect Dis. 2019 Sep;38(9):1633-1641. doi: 10.1007/s10096-019-03591-2. Epub 2019 May 28.

PMID:
31140071
28.

Advancing preparedness for clinical research during infectious disease epidemics.

Gobat N, Amuasi J, Yazdanpanah Y, Sigfid L, Davies H, Byrne JP, Carson G, Butler C, Nichol A, Goossens H.

ERJ Open Res. 2019 May 20;5(2). pii: 00227-2018. doi: 10.1183/23120541.00227-2018. eCollection 2019 Apr. Erratum in: ERJ Open Res. 2019 Jul 29;5(3):.

29.

Remarkable Genome Stability among emm1 Group A Streptococcus in Belgium over 19 Years.

Coppens J, Xavier BB, Loens K, Lammens C, Ieven M, Matheeussen V, Goossens H, Malhotra-Kumar S.

Genome Biol Evol. 2019 May 1;11(5):1432-1439. doi: 10.1093/gbe/evz093.

30.

Emergence of colistin resistance during treatment of recurrent pneumonia caused by carbapenemase producing Klebsiella pneumoniae.

Matheeussen V, Xavier BB, Mermans I, De Weerdt A, Lammens C, Goossens H, Jansens H, Malhotra-Kumar S.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):407-409. doi: 10.1016/j.diagmicrobio.2019.02.014. Epub 2019 Feb 21.

PMID:
30890297
31.

Comparison of the Power of Procalcitonin and C-Reactive Protein to Discriminate between Different Aetiologies of Fever in Prolonged Profound Neutropenia: A Single-Centre Prospective Observational Study.

Verlinden A, De Vroey V, Goossens H, Roelant E, Van De Velde AL, Berneman ZN, Schroyens WA, Gadisseur AP.

Mediterr J Hematol Infect Dis. 2019 Mar 1;11(1):e2019023. doi: 10.4084/MJHID.2019.023. eCollection 2019.

32.

Antibiotic Prescribing for Acute Respiratory Tract Infections 12 Months After Communication and CRP Training: A Randomized Trial.

Little P, Stuart B, Francis N, Douglas E, Tonkin-Crine S, Anthierens S, Cals JWL, Melbye H, Santer M, Moore M, Coenen S, Butler CC, Hood K, Kelson M, Godycki-Cwirko M, Mierzecki A, Torres A, Llor C, Davies M, Mullee M, O'Reilly G, van der Velden A, Geraghty AWA, Goossens H, Verheij T, Yardley L; GRACE consortium.

Ann Fam Med. 2019 Mar;17(2):125-132. doi: 10.1370/afm.2356.

33.
34.

Comparison of the Coris Influ A + B K-SeT® and BD Veritor Flu A + B® for rapid detection of influenza viruses in respiratory samples from 3 consecutive flu seasons in Belgium.

Vandamme S, Van Cleempoel S, Michiels M, Goossens H, Jansens H, Matheeussen V.

Diagn Microbiol Infect Dis. 2019 Jul;94(3):227-230. doi: 10.1016/j.diagmicrobio.2019.01.005. Epub 2019 Jan 25. No abstract available.

PMID:
30827806
35.

A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications.

Saleem Z, Hassali MA, Versporten A, Godman B, Hashmi FK, Goossens H, Saleem F.

Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293. doi: 10.1080/14787210.2019.1581063. Epub 2019 Feb 22.

36.

Potential in vivo transfer of a blaCTX-M14-harbouring plasmid established by combining long- and short-read sequencing.

Xavier BB, Renzi G, Lammens C, Cherkaoui A, Goossens H, Schrenzel J, Harbarth S, Malhotra-Kumar S.

J Microbiol Methods. 2019 Apr;159:1-4. doi: 10.1016/j.mimet.2019.02.004. Epub 2019 Feb 7.

PMID:
30738818
37.

Point prevalence survey of antimicrobial prescription in a tertiary hospital in South East Nigeria: A call for improved antibiotic stewardship.

Umeokonkwo CD, Madubueze UC, Onah CK, Okedo-Alex IN, Adeke AS, Versporten A, Goossens H, Igwe-Okomiso D, Okeke K, Azuogu BN, Onoh R.

J Glob Antimicrob Resist. 2019 Jun;17:291-295. doi: 10.1016/j.jgar.2019.01.013. Epub 2019 Jan 19.

PMID:
30668994
38.

Comparison of GeneXpert MRSA/SA ETA assay with semi-quantitative and quantitative cultures and nuc gene-based qPCR for detection of Staphylococcus aureus in endotracheal aspirate samples.

Coppens J, Van Heirstraeten L, Ruzin A, Yu L, Timbermont L, Lammens C, Matheeussen V, McCarthy M, Jorens P, Ieven M, Kumar-Singh S, Goossens H, Malhotra-Kumar S.

Antimicrob Resist Infect Control. 2019 Jan 5;8:4. doi: 10.1186/s13756-018-0460-8. eCollection 2019.

39.

The economics of antibiotic resistance: a claim for personalised treatments.

Antoñanzas F, Goossens H.

Eur J Health Econ. 2019 Jun;20(4):483-485. doi: 10.1007/s10198-018-1021-z. No abstract available.

PMID:
30560434
40.

Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR Mispairing.

Campillo-Davo D, Fujiki F, Van den Bergh JMJ, De Reu H, Smits ELJM, Goossens H, Sugiyama H, Lion E, Berneman ZN, Van Tendeloo V.

Front Immunol. 2018 Nov 7;9:2503. doi: 10.3389/fimmu.2018.02503. eCollection 2018.

41.

ABSTRACTPerformance of the new Illumigene® Mycoplasma LAMP assay for detection of M. pneumonia.

Musger L, Matheeussen V, Loens K, Goossens H.

Acta Clin Belg. 2018 Nov;73(sup1):1-9. doi: 10.1080/17843286.2018.1538724. No abstract available.

PMID:
30430927
42.

Reply to Charra et al.: Global longitudinal assessment of 2019 changes in defined daily doses.

Klein EY, Tseng KK, Levin SA, Goossens H, Laxminarayan R.

Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):E11433-E11435. doi: 10.1073/pnas.1817182115. Epub 2018 Nov 13. No abstract available.

43.

Comparative point prevalence survey of antimicrobial consumption between a hospital in Northern Ireland and a hospital in Jordan.

Elhajji FD, Al-Taani GM, Anani L, Al-Masri S, Abdalaziz H, Qabba'h SH, Al Bawab AQ, Scott M, Farren D, Gilmore F, Versporten A, Goossens H, Aldeyab MA.

BMC Health Serv Res. 2018 Nov 12;18(1):849. doi: 10.1186/s12913-018-3656-y.

44.

Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey.

Kostyanev T, Vilken T, Lammens C, Timbermont L, Van't Veen A, Goossens H.

Int J Antimicrob Agents. 2019 Mar;53(3):268-274. doi: 10.1016/j.ijantimicag.2018.10.013. Epub 2018 Oct 31.

45.

Enzymes Catalyzing the TCA- and Urea Cycle Influence the Matrix Composition of Biofilms Formed by Methicillin-Resistant Staphylococcus aureus USA300.

De Backer S, Sabirova J, De Pauw I, De Greve H, Hernalsteens JP, Goossens H, Malhotra-Kumar S.

Microorganisms. 2018 Oct 29;6(4). pii: E113. doi: 10.3390/microorganisms6040113.

46.

Novel composite SCCmec type III element in ST239 MRSA isolated from an Indian hospital.

Coppens J, Xavier BB, Vanjari L, De Backer S, Lammens C, Vemu L, Goossens H, Malhotra-Kumar S.

J Antimicrob Chemother. 2019 Jan 1;74(1):264-266. doi: 10.1093/jac/dky399. No abstract available.

PMID:
30285123
47.

Cost-effectiveness of internet-based training for primary care clinicians on antibiotic prescribing for acute respiratory tract infections in Europe.

Oppong R, Smith RD, Little P, Verheij T, Butler CC, Goossens H, Coenen S, Jowett S, Roberts TE, Achana F, Stuart B, Coast J.

J Antimicrob Chemother. 2018 Nov 1;73(11):3189-3198. doi: 10.1093/jac/dky309.

PMID:
30165522
48.

Remarkable geographical variations between India and Europe in carriage of the staphylococcal surface protein-encoding sasX/sesI and in the population structure of methicillin-resistant Staphylococcus aureus belonging to clonal complex 8.

De Backer S, Xavier BB, Vanjari L, Coppens J, Lammens C, Vemu L, Carevic B, Hryniewicz W, Jorens P, Kumar-Singh S, Lee A, Harbarth S, Schrenzel J, Tacconelli E, Goossens H, Malhotra-Kumar S.

Clin Microbiol Infect. 2019 May;25(5):628.e1-628.e7. doi: 10.1016/j.cmi.2018.07.024. Epub 2018 Aug 2.

PMID:
30076977
49.

Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.

Gal M, Francis NA, Hood K, Villacian J, Goossens H, Watkins A, Butler CC; RAPP-ID consortium.

PLoS One. 2018 Aug 1;13(8):e0200531. doi: 10.1371/journal.pone.0200531. eCollection 2018.

50.

Clinical relevance of bacterial resistance in lower respiratory tract infection in primary care: secondary analysis of a multicentre European trial.

Teepe J, Broekhuizen BD, Goossens H, Hordijk PM, Loens K, Lammens C, Ieven M, Little P, Butler CC, Coenen S, Godycki-Cwirko M, Henriques-Normark B, Verheij TJ; GRACE consortium.

Br J Gen Pract. 2018 Sep;68(674):e627-e632. doi: 10.3399/bjgp18X698333. Epub 2018 Jul 30.

Supplemental Content

Loading ...
Support Center